Published on Friday March 02, 2018

In February 2018, the Smooth Drug Development team attended the SCOPE conference, which took place on Orlando, FL, USA. In four days of the conference, our team conducted a survey, which engaged 54 participants from different western companies. Respondents shared their experience of clinical research conduct in Russia and Eastern Europe and expressed their perception of the clinical trials market in this region. How do professionals evaluate clinical trials market in Russia and post-Socialist space? Did the Russiagate influence the perception of clinical trials conduct in Russia? What is the most trustworthy country in the post-Soviet area? If you are interested to learn about the results of our survey, please follow this link.

This survey is a part of a bigger project for studying Russian and Eastern European clinical research market. If you'd interested in learning more about this region, follow our news on website or blog on LinkedIn.

If you have any comments or suggestions for the future studies, contact us at